As shown in Table 4, the performance of ΔMoRAL in predicting OS was significantly better than the performances of initial respective serum tumor markers, baseline MoRAL score, and changes in serum tumor markers, except for the baseline AFP level, in both the training and hospital validation cohorts (all p < 0.05). Here, AFP is linked to neoplasm.